The focus of the meeting was relevant for the management of drug treatment in the Common Customs Union between Republic of Belarus, Kazakhstan and the Russian Federation. The event was organized by the Ministry of Health of the Republic of Belarus and the Association of International Pharmaceutical Manufacturers. The conference was attended by representatives of legislative, executive bodies, and public organizations from Belarus, Kazakhstan, Russia, and Ukraine. In anticipation of the symposium was held a meeting of heads of industry associations of the states, which resulted in consideration of the Secretariat of Customs Union Commission adopted a resolution. The draft refers to the introduction of common principles for the formation of restrictive lists of medicines, transparent process and fair competition at the level of public procurement. The document key points were proposals by Victor Dmitriev- the Director of the Association of Russian Pharmaceutical Manufacturers. He noted the importance to determine the conditions and timing of the introduction of international standards GMP, more intensive development of international projects for cooperation, and licensing manufacturing services. In the area of the drugs registration were suggested the introduction of uniform requirements for registration documents. Creating a unified electronic platform for regulators, and creating a single electronic registry of drugs interstate. The resolution focused on the mutual recognition of results of preclinical and clinical researches, registration certificates, and the creation of a common national Pharmacopoeia.

To improve the pharmacovigilance system in the Customs Union should be created a unified system of monitoring the safety of drugs. It is important to  create and to implement the on-line electronic information system for serious adverse reactions. For a successful fight against counterfeit drugs it is necessary to establish the International Coordination Council. Also refine requires regulatory and legal framework to harmonise the profile and terms,  unification acts in health care, advertising, and drugs and anti-monopoly regulation.  
Participants also asked the Secretariat of the Commission of the Customs Union with the proposal to establish a committee on drug treatment and conditions of a single customs territory at a business center of the economic development of the CIS. 

« The Adoption of the draft resolution will expand opportunities for business and would reduce the restrictive barriers that exist today. Since the main objective of pharmaceutical companies is to provide people with quality medicines, it is important to expand bilateral relations and to form a single customs territory. It is gratifying that the intellectual capacity and experience gained industry associations, are in great demand and will be included in the regulations governing the handling of medicines within the Common Customs Union» -the General Director Victor Dmitriev has underlined. 

The Association of Russian Pharmaceutical Manufacturers represents the interests of Russian pharmaceutical manufacturers, and facilitates the improved competitiveness of the domestic pharmaceutical industry. A key objective is to assist Russian manufacturers in the changeover to the new GMP and/or ISO standards.  www.arfp.ru